nodes	percent_of_prediction	percent_of_DWPC	metapath
Cimetidine—CYP3A4—bone cancer	0.378	1	CbGaD
Cimetidine—ABCB11—Doxorubicin—bone cancer	0.0765	0.173	CbGbCtD
Cimetidine—SLC22A2—Cisplatin—bone cancer	0.0735	0.166	CbGbCtD
Cimetidine—SLC22A11—Methotrexate—bone cancer	0.0704	0.159	CbGbCtD
Cimetidine—SLC22A7—Methotrexate—bone cancer	0.0671	0.151	CbGbCtD
Cimetidine—SLC22A8—Methotrexate—bone cancer	0.041	0.0925	CbGbCtD
Cimetidine—SLC22A6—Methotrexate—bone cancer	0.0285	0.0644	CbGbCtD
Cimetidine—CYP2C9—Cisplatin—bone cancer	0.0202	0.0456	CbGbCtD
Cimetidine—ABCB1—Cisplatin—bone cancer	0.0196	0.0442	CbGbCtD
Cimetidine—ABCB1—Doxorubicin—bone cancer	0.0131	0.0296	CbGbCtD
Cimetidine—ABCB1—Methotrexate—bone cancer	0.0127	0.0287	CbGbCtD
Cimetidine—CYP2D6—Doxorubicin—bone cancer	0.0124	0.0279	CbGbCtD
Cimetidine—Hepatic fibrosis—Methotrexate—bone cancer	0.0112	0.126	CcSEcCtD
Cimetidine—CYP3A4—Doxorubicin—bone cancer	0.00786	0.0177	CbGbCtD
Cimetidine—Hepatic insufficiency—Methotrexate—bone cancer	0.00436	0.0491	CcSEcCtD
Cimetidine—Immunodeficiency—Methotrexate—bone cancer	0.00389	0.0438	CcSEcCtD
Cimetidine—Necrolysis epidermal—Methotrexate—bone cancer	0.00297	0.0335	CcSEcCtD
Cimetidine—Alopecia reversible—Epirubicin—bone cancer	0.00278	0.0313	CcSEcCtD
Cimetidine—Alopecia reversible—Doxorubicin—bone cancer	0.00257	0.029	CcSEcCtD
Cimetidine—Allergic cutaneous angiitis—Methotrexate—bone cancer	0.00212	0.0239	CcSEcCtD
Cimetidine—Hepatotoxicity—Cisplatin—bone cancer	0.00159	0.0179	CcSEcCtD
Cimetidine—Liver injury—Cisplatin—bone cancer	0.00146	0.0165	CcSEcCtD
Cimetidine—Leukocytoclastic vasculitis—Methotrexate—bone cancer	0.00138	0.0155	CcSEcCtD
Cimetidine—Body temperature increased—Carboplatin—bone cancer	0.00118	0.0133	CcSEcCtD
Cimetidine—Bone marrow depression—Methotrexate—bone cancer	0.000999	0.0113	CcSEcCtD
Cimetidine—Bone marrow depression—Epirubicin—bone cancer	0.000935	0.0105	CcSEcCtD
Cimetidine—Hepatotoxicity—Methotrexate—bone cancer	0.000874	0.00984	CcSEcCtD
Cimetidine—Bone marrow depression—Doxorubicin—bone cancer	0.000865	0.00974	CcSEcCtD
Cimetidine—Blood creatinine increased—Cisplatin—bone cancer	0.000836	0.00941	CcSEcCtD
Cimetidine—Pancreatitis—Cisplatin—bone cancer	0.000756	0.00852	CcSEcCtD
Cimetidine—Liver injury—Epirubicin—bone cancer	0.00075	0.00845	CcSEcCtD
Cimetidine—Pancytopenia—Cisplatin—bone cancer	0.000732	0.00825	CcSEcCtD
Cimetidine—Liver injury—Doxorubicin—bone cancer	0.000694	0.00782	CcSEcCtD
Cimetidine—Renal failure—Cisplatin—bone cancer	0.000676	0.00761	CcSEcCtD
Cimetidine—Atrioventricular block—Epirubicin—bone cancer	0.000651	0.00733	CcSEcCtD
Cimetidine—Musculoskeletal pain—Epirubicin—bone cancer	0.000639	0.0072	CcSEcCtD
Cimetidine—Aplastic anaemia—Methotrexate—bone cancer	0.000633	0.00713	CcSEcCtD
Cimetidine—Bradycardia—Cisplatin—bone cancer	0.000628	0.00708	CcSEcCtD
Cimetidine—Gynaecomastia—Methotrexate—bone cancer	0.000604	0.0068	CcSEcCtD
Cimetidine—Atrioventricular block—Doxorubicin—bone cancer	0.000602	0.00678	CcSEcCtD
Cimetidine—Aplastic anaemia—Epirubicin—bone cancer	0.000593	0.00667	CcSEcCtD
Cimetidine—Musculoskeletal pain—Doxorubicin—bone cancer	0.000591	0.00666	CcSEcCtD
Cimetidine—Aplastic anaemia—Doxorubicin—bone cancer	0.000548	0.00618	CcSEcCtD
Cimetidine—Alopecia—Cisplatin—bone cancer	0.000546	0.00614	CcSEcCtD
Cimetidine—Hepatic failure—Methotrexate—bone cancer	0.000545	0.00614	CcSEcCtD
Cimetidine—Flatulence—Cisplatin—bone cancer	0.00053	0.00596	CcSEcCtD
Cimetidine—Dermatitis exfoliative—Methotrexate—bone cancer	0.000519	0.00584	CcSEcCtD
Cimetidine—Hepatic failure—Epirubicin—bone cancer	0.00051	0.00574	CcSEcCtD
Cimetidine—Dermatitis exfoliative—Epirubicin—bone cancer	0.000486	0.00547	CcSEcCtD
Cimetidine—Malaise—Cisplatin—bone cancer	0.000485	0.00546	CcSEcCtD
Cimetidine—Renal impairment—Epirubicin—bone cancer	0.000482	0.00542	CcSEcCtD
Cimetidine—Leukopenia—Cisplatin—bone cancer	0.000481	0.00542	CcSEcCtD
Cimetidine—Hepatic failure—Doxorubicin—bone cancer	0.000472	0.00531	CcSEcCtD
Cimetidine—Myalgia—Cisplatin—bone cancer	0.000458	0.00515	CcSEcCtD
Cimetidine—Anxiety—Cisplatin—bone cancer	0.000456	0.00513	CcSEcCtD
Cimetidine—Dermatitis exfoliative—Doxorubicin—bone cancer	0.000449	0.00506	CcSEcCtD
Cimetidine—Renal impairment—Doxorubicin—bone cancer	0.000446	0.00502	CcSEcCtD
Cimetidine—Toxic epidermal necrolysis—Methotrexate—bone cancer	0.000441	0.00497	CcSEcCtD
Cimetidine—Anaphylactic shock—Cisplatin—bone cancer	0.000439	0.00494	CcSEcCtD
Cimetidine—Thrombocytopenia—Cisplatin—bone cancer	0.000429	0.00484	CcSEcCtD
Cimetidine—Blood creatinine increased—Epirubicin—bone cancer	0.000429	0.00483	CcSEcCtD
Cimetidine—Tachycardia—Cisplatin—bone cancer	0.000428	0.00482	CcSEcCtD
Cimetidine—Pancreatitis—Methotrexate—bone cancer	0.000415	0.00467	CcSEcCtD
Cimetidine—Toxic epidermal necrolysis—Epirubicin—bone cancer	0.000413	0.00465	CcSEcCtD
Cimetidine—Pancytopenia—Methotrexate—bone cancer	0.000402	0.00453	CcSEcCtD
Cimetidine—Musculoskeletal discomfort—Cisplatin—bone cancer	0.0004	0.0045	CcSEcCtD
Cimetidine—Blood creatinine increased—Doxorubicin—bone cancer	0.000397	0.00447	CcSEcCtD
Cimetidine—Neutropenia—Methotrexate—bone cancer	0.000396	0.00446	CcSEcCtD
Cimetidine—Erectile dysfunction—Methotrexate—bone cancer	0.00039	0.00439	CcSEcCtD
Cimetidine—Pancreatitis—Epirubicin—bone cancer	0.000388	0.00437	CcSEcCtD
Cimetidine—Toxic epidermal necrolysis—Doxorubicin—bone cancer	0.000382	0.0043	CcSEcCtD
Cimetidine—Pneumonia—Methotrexate—bone cancer	0.00038	0.00427	CcSEcCtD
Cimetidine—Drowsiness—Methotrexate—bone cancer	0.000377	0.00425	CcSEcCtD
Cimetidine—Pancytopenia—Epirubicin—bone cancer	0.000376	0.00424	CcSEcCtD
Cimetidine—Stevens-Johnson syndrome—Methotrexate—bone cancer	0.000374	0.00421	CcSEcCtD
Cimetidine—Renal failure—Methotrexate—bone cancer	0.000371	0.00418	CcSEcCtD
Cimetidine—Neutropenia—Epirubicin—bone cancer	0.00037	0.00417	CcSEcCtD
Cimetidine—Feeling abnormal—Cisplatin—bone cancer	0.000361	0.00407	CcSEcCtD
Cimetidine—Pancreatitis—Doxorubicin—bone cancer	0.000359	0.00405	CcSEcCtD
Cimetidine—Pneumonia—Epirubicin—bone cancer	0.000355	0.004	CcSEcCtD
Cimetidine—Drowsiness—Epirubicin—bone cancer	0.000353	0.00398	CcSEcCtD
Cimetidine—Agranulocytosis—Methotrexate—bone cancer	0.000352	0.00397	CcSEcCtD
Cimetidine—Stevens-Johnson syndrome—Epirubicin—bone cancer	0.00035	0.00394	CcSEcCtD
Cimetidine—Pancytopenia—Doxorubicin—bone cancer	0.000348	0.00392	CcSEcCtD
Cimetidine—Renal failure—Epirubicin—bone cancer	0.000347	0.00391	CcSEcCtD
Cimetidine—Body temperature increased—Cisplatin—bone cancer	0.000347	0.0039	CcSEcCtD
Cimetidine—Neutropenia—Doxorubicin—bone cancer	0.000343	0.00386	CcSEcCtD
Cimetidine—Hepatitis—Methotrexate—bone cancer	0.000339	0.00381	CcSEcCtD
Cimetidine—Agranulocytosis—Epirubicin—bone cancer	0.00033	0.00371	CcSEcCtD
Cimetidine—Pneumonia—Doxorubicin—bone cancer	0.000329	0.0037	CcSEcCtD
Cimetidine—Drowsiness—Doxorubicin—bone cancer	0.000327	0.00368	CcSEcCtD
Cimetidine—Stevens-Johnson syndrome—Doxorubicin—bone cancer	0.000324	0.00365	CcSEcCtD
Cimetidine—Hypersensitivity—Cisplatin—bone cancer	0.000323	0.00364	CcSEcCtD
Cimetidine—Bradycardia—Epirubicin—bone cancer	0.000323	0.00363	CcSEcCtD
Cimetidine—Renal failure—Doxorubicin—bone cancer	0.000321	0.00362	CcSEcCtD
Cimetidine—Erythema multiforme—Methotrexate—bone cancer	0.00032	0.00361	CcSEcCtD
Cimetidine—Hepatitis—Epirubicin—bone cancer	0.000317	0.00357	CcSEcCtD
Cimetidine—Asthenia—Cisplatin—bone cancer	0.000315	0.00354	CcSEcCtD
Cimetidine—Agranulocytosis—Doxorubicin—bone cancer	0.000305	0.00343	CcSEcCtD
Cimetidine—Diarrhoea—Cisplatin—bone cancer	0.0003	0.00338	CcSEcCtD
Cimetidine—Erythema multiforme—Epirubicin—bone cancer	0.0003	0.00338	CcSEcCtD
Cimetidine—Alopecia—Methotrexate—bone cancer	0.000299	0.00337	CcSEcCtD
Cimetidine—Bradycardia—Doxorubicin—bone cancer	0.000299	0.00336	CcSEcCtD
Cimetidine—Hepatitis—Doxorubicin—bone cancer	0.000293	0.0033	CcSEcCtD
Cimetidine—Alopecia—Epirubicin—bone cancer	0.00028	0.00315	CcSEcCtD
Cimetidine—Vomiting—Cisplatin—bone cancer	0.000279	0.00314	CcSEcCtD
Cimetidine—Erythema multiforme—Doxorubicin—bone cancer	0.000277	0.00312	CcSEcCtD
Cimetidine—Rash—Cisplatin—bone cancer	0.000277	0.00311	CcSEcCtD
Cimetidine—Dermatitis—Cisplatin—bone cancer	0.000276	0.00311	CcSEcCtD
Cimetidine—Flatulence—Epirubicin—bone cancer	0.000272	0.00306	CcSEcCtD
Cimetidine—Malaise—Methotrexate—bone cancer	0.000266	0.00299	CcSEcCtD
Cimetidine—Leukopenia—Methotrexate—bone cancer	0.000264	0.00297	CcSEcCtD
Cimetidine—Nausea—Cisplatin—bone cancer	0.000261	0.00293	CcSEcCtD
Cimetidine—Alopecia—Doxorubicin—bone cancer	0.000259	0.00292	CcSEcCtD
Cimetidine—Agitation—Epirubicin—bone cancer	0.000254	0.00286	CcSEcCtD
Cimetidine—Flatulence—Doxorubicin—bone cancer	0.000252	0.00283	CcSEcCtD
Cimetidine—Arthralgia—Methotrexate—bone cancer	0.000251	0.00283	CcSEcCtD
Cimetidine—Myalgia—Methotrexate—bone cancer	0.000251	0.00283	CcSEcCtD
Cimetidine—Malaise—Epirubicin—bone cancer	0.000249	0.0028	CcSEcCtD
Cimetidine—Leukopenia—Epirubicin—bone cancer	0.000247	0.00278	CcSEcCtD
Cimetidine—Confusional state—Methotrexate—bone cancer	0.000243	0.00273	CcSEcCtD
Cimetidine—Anaphylactic shock—Methotrexate—bone cancer	0.000241	0.00271	CcSEcCtD
Cimetidine—Thrombocytopenia—Methotrexate—bone cancer	0.000236	0.00265	CcSEcCtD
Cimetidine—Arthralgia—Epirubicin—bone cancer	0.000235	0.00265	CcSEcCtD
Cimetidine—Myalgia—Epirubicin—bone cancer	0.000235	0.00265	CcSEcCtD
Cimetidine—Agitation—Doxorubicin—bone cancer	0.000235	0.00264	CcSEcCtD
Cimetidine—Anxiety—Epirubicin—bone cancer	0.000234	0.00264	CcSEcCtD
Cimetidine—Malaise—Doxorubicin—bone cancer	0.00023	0.00259	CcSEcCtD
Cimetidine—Leukopenia—Doxorubicin—bone cancer	0.000229	0.00257	CcSEcCtD
Cimetidine—Confusional state—Epirubicin—bone cancer	0.000227	0.00256	CcSEcCtD
Cimetidine—Anaphylactic shock—Epirubicin—bone cancer	0.000225	0.00254	CcSEcCtD
Cimetidine—Thrombocytopenia—Epirubicin—bone cancer	0.000221	0.00248	CcSEcCtD
Cimetidine—Tachycardia—Epirubicin—bone cancer	0.00022	0.00248	CcSEcCtD
Cimetidine—Musculoskeletal discomfort—Methotrexate—bone cancer	0.000219	0.00247	CcSEcCtD
Cimetidine—Arthralgia—Doxorubicin—bone cancer	0.000217	0.00245	CcSEcCtD
Cimetidine—Myalgia—Doxorubicin—bone cancer	0.000217	0.00245	CcSEcCtD
Cimetidine—Anxiety—Doxorubicin—bone cancer	0.000217	0.00244	CcSEcCtD
Cimetidine—Somnolence—Methotrexate—bone cancer	0.000214	0.00241	CcSEcCtD
Cimetidine—Confusional state—Doxorubicin—bone cancer	0.00021	0.00237	CcSEcCtD
Cimetidine—Anaphylactic shock—Doxorubicin—bone cancer	0.000208	0.00235	CcSEcCtD
Cimetidine—Fatigue—Methotrexate—bone cancer	0.000208	0.00234	CcSEcCtD
Cimetidine—Musculoskeletal discomfort—Epirubicin—bone cancer	0.000205	0.00231	CcSEcCtD
Cimetidine—Thrombocytopenia—Doxorubicin—bone cancer	0.000204	0.0023	CcSEcCtD
Cimetidine—Tachycardia—Doxorubicin—bone cancer	0.000203	0.00229	CcSEcCtD
Cimetidine—Somnolence—Epirubicin—bone cancer	0.0002	0.00225	CcSEcCtD
Cimetidine—Feeling abnormal—Methotrexate—bone cancer	0.000198	0.00223	CcSEcCtD
Cimetidine—Fatigue—Epirubicin—bone cancer	0.000194	0.00219	CcSEcCtD
Cimetidine—Constipation—Epirubicin—bone cancer	0.000193	0.00217	CcSEcCtD
Cimetidine—Body temperature increased—Methotrexate—bone cancer	0.00019	0.00214	CcSEcCtD
Cimetidine—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.00019	0.00214	CcSEcCtD
Cimetidine—Feeling abnormal—Epirubicin—bone cancer	0.000186	0.00209	CcSEcCtD
Cimetidine—Somnolence—Doxorubicin—bone cancer	0.000185	0.00209	CcSEcCtD
Cimetidine—Fatigue—Doxorubicin—bone cancer	0.00018	0.00202	CcSEcCtD
Cimetidine—Constipation—Doxorubicin—bone cancer	0.000178	0.00201	CcSEcCtD
Cimetidine—Body temperature increased—Epirubicin—bone cancer	0.000178	0.00201	CcSEcCtD
Cimetidine—Hypersensitivity—Methotrexate—bone cancer	0.000177	0.002	CcSEcCtD
Cimetidine—Asthenia—Methotrexate—bone cancer	0.000173	0.00194	CcSEcCtD
Cimetidine—Feeling abnormal—Doxorubicin—bone cancer	0.000172	0.00193	CcSEcCtD
Cimetidine—Hypersensitivity—Epirubicin—bone cancer	0.000166	0.00187	CcSEcCtD
Cimetidine—Body temperature increased—Doxorubicin—bone cancer	0.000165	0.00186	CcSEcCtD
Cimetidine—Diarrhoea—Methotrexate—bone cancer	0.000165	0.00185	CcSEcCtD
Cimetidine—Asthenia—Epirubicin—bone cancer	0.000162	0.00182	CcSEcCtD
Cimetidine—Dizziness—Methotrexate—bone cancer	0.000159	0.00179	CcSEcCtD
Cimetidine—Diarrhoea—Epirubicin—bone cancer	0.000154	0.00174	CcSEcCtD
Cimetidine—Hypersensitivity—Doxorubicin—bone cancer	0.000154	0.00173	CcSEcCtD
Cimetidine—Vomiting—Methotrexate—bone cancer	0.000153	0.00172	CcSEcCtD
Cimetidine—Rash—Methotrexate—bone cancer	0.000152	0.00171	CcSEcCtD
Cimetidine—Dermatitis—Methotrexate—bone cancer	0.000152	0.00171	CcSEcCtD
Cimetidine—Headache—Methotrexate—bone cancer	0.000151	0.0017	CcSEcCtD
Cimetidine—Asthenia—Doxorubicin—bone cancer	0.00015	0.00168	CcSEcCtD
Cimetidine—Dizziness—Epirubicin—bone cancer	0.000149	0.00168	CcSEcCtD
Cimetidine—Vomiting—Epirubicin—bone cancer	0.000143	0.00161	CcSEcCtD
Cimetidine—Nausea—Methotrexate—bone cancer	0.000143	0.00161	CcSEcCtD
Cimetidine—Diarrhoea—Doxorubicin—bone cancer	0.000143	0.00161	CcSEcCtD
Cimetidine—CYP2C19—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000142	0.00156	CbGpPWpGaD
Cimetidine—Rash—Epirubicin—bone cancer	0.000142	0.0016	CcSEcCtD
Cimetidine—Dermatitis—Epirubicin—bone cancer	0.000142	0.0016	CcSEcCtD
Cimetidine—SLC22A5—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000142	0.00156	CbGpPWpGaD
Cimetidine—Headache—Epirubicin—bone cancer	0.000141	0.00159	CcSEcCtD
Cimetidine—Dizziness—Doxorubicin—bone cancer	0.000138	0.00155	CcSEcCtD
Cimetidine—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000137	0.0015	CbGpPWpGaD
Cimetidine—CYP11B1—Metabolism—NT5C3A—bone cancer	0.000136	0.0015	CbGpPWpGaD
Cimetidine—HRH2—GPCR ligand binding—SMO—bone cancer	0.000136	0.0015	CbGpPWpGaD
Cimetidine—CYP3A7—Biological oxidations—CYP3A4—bone cancer	0.000135	0.00149	CbGpPWpGaD
Cimetidine—CYP1A2—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000135	0.00148	CbGpPWpGaD
Cimetidine—Nausea—Epirubicin—bone cancer	0.000134	0.00151	CcSEcCtD
Cimetidine—CYP3A7—Metapathway biotransformation—CYP3A4—bone cancer	0.000133	0.00147	CbGpPWpGaD
Cimetidine—Vomiting—Doxorubicin—bone cancer	0.000133	0.00149	CcSEcCtD
Cimetidine—Rash—Doxorubicin—bone cancer	0.000131	0.00148	CcSEcCtD
Cimetidine—Dermatitis—Doxorubicin—bone cancer	0.000131	0.00148	CcSEcCtD
Cimetidine—CYP2D6—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000131	0.00144	CbGpPWpGaD
Cimetidine—Headache—Doxorubicin—bone cancer	0.000131	0.00147	CcSEcCtD
Cimetidine—CYP2C9—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000129	0.00143	CbGpPWpGaD
Cimetidine—CYP2E1—Tryptophan metabolism—MDM2—bone cancer	0.000129	0.00142	CbGpPWpGaD
Cimetidine—SLC22A3—Metabolism—NDUFA12—bone cancer	0.000129	0.00142	CbGpPWpGaD
Cimetidine—SLC22A8—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000128	0.00141	CbGpPWpGaD
Cimetidine—HRH2—GPCR downstream signaling—GRM4—bone cancer	0.000126	0.00138	CbGpPWpGaD
Cimetidine—HRH2—GPCR downstream signaling—RGS1—bone cancer	0.000126	0.00138	CbGpPWpGaD
Cimetidine—SLC22A6—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000124	0.00137	CbGpPWpGaD
Cimetidine—Nausea—Doxorubicin—bone cancer	0.000124	0.00139	CcSEcCtD
Cimetidine—ABCB11—Metabolism—NDUFA12—bone cancer	0.000123	0.00136	CbGpPWpGaD
Cimetidine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—bone cancer	0.000117	0.00129	CbGpPWpGaD
Cimetidine—CYP3A7—Biological oxidations—GSTP1—bone cancer	0.000115	0.00127	CbGpPWpGaD
Cimetidine—HRH2—Signaling by GPCR—GRM4—bone cancer	0.000114	0.00126	CbGpPWpGaD
Cimetidine—HRH2—Signaling by GPCR—RGS1—bone cancer	0.000114	0.00126	CbGpPWpGaD
Cimetidine—CYP3A7—Metapathway biotransformation—GSTP1—bone cancer	0.000114	0.00125	CbGpPWpGaD
Cimetidine—CYP1A2—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000111	0.00122	CbGpPWpGaD
Cimetidine—HRH2—GPCR downstream signaling—GRM1—bone cancer	0.000109	0.0012	CbGpPWpGaD
Cimetidine—SLC22A6—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000107	0.00118	CbGpPWpGaD
Cimetidine—SLC22A3—Metabolism—NT5C3A—bone cancer	0.000107	0.00118	CbGpPWpGaD
Cimetidine—SLC22A2—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000103	0.00114	CbGpPWpGaD
Cimetidine—ABCB11—Metabolism—NT5C3A—bone cancer	0.000102	0.00113	CbGpPWpGaD
Cimetidine—FMO1—Metabolism—ENO2—bone cancer	0.000101	0.00112	CbGpPWpGaD
Cimetidine—CYP2C8—Arachidonic acid metabolism—PTGS2—bone cancer	0.000101	0.00111	CbGpPWpGaD
Cimetidine—HRH2—Signaling by GPCR—GRM1—bone cancer	9.89e-05	0.00109	CbGpPWpGaD
Cimetidine—CYP2E1—Biological oxidations—CYP3A4—bone cancer	9.78e-05	0.00108	CbGpPWpGaD
Cimetidine—CYP3A5—Biological oxidations—CYP3A4—bone cancer	9.76e-05	0.00107	CbGpPWpGaD
Cimetidine—CYP2E1—Metapathway biotransformation—CYP3A4—bone cancer	9.64e-05	0.00106	CbGpPWpGaD
Cimetidine—SLC22A1—Transmembrane transport of small molecules—TUBB4B—bone cancer	9.63e-05	0.00106	CbGpPWpGaD
Cimetidine—CYP3A5—Metapathway biotransformation—CYP3A4—bone cancer	9.62e-05	0.00106	CbGpPWpGaD
Cimetidine—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—bone cancer	9.6e-05	0.00106	CbGpPWpGaD
Cimetidine—FMO1—Metabolism—DHFR—bone cancer	9.42e-05	0.00104	CbGpPWpGaD
Cimetidine—CYP1A2—Aryl Hydrocarbon Receptor—RB1—bone cancer	9.1e-05	0.001	CbGpPWpGaD
Cimetidine—CYP2C19—Arachidonic acid metabolism—PTGS2—bone cancer	8.98e-05	0.000989	CbGpPWpGaD
Cimetidine—SLC22A2—Transmembrane transport of small molecules—TUBB2A—bone cancer	8.92e-05	0.000982	CbGpPWpGaD
Cimetidine—FMO1—Metabolism—GNA11—bone cancer	8.8e-05	0.000969	CbGpPWpGaD
Cimetidine—CYP1A2—Phase II conjugation—GSTP1—bone cancer	8.59e-05	0.000946	CbGpPWpGaD
Cimetidine—CYP2C8—Biological oxidations—CYP3A4—bone cancer	8.45e-05	0.000931	CbGpPWpGaD
Cimetidine—CYP2E1—Biological oxidations—GSTP1—bone cancer	8.36e-05	0.000921	CbGpPWpGaD
Cimetidine—CYP3A5—Biological oxidations—GSTP1—bone cancer	8.35e-05	0.000919	CbGpPWpGaD
Cimetidine—CYP2C8—Metapathway biotransformation—CYP3A4—bone cancer	8.34e-05	0.000918	CbGpPWpGaD
Cimetidine—SLC22A1—Transmembrane transport of small molecules—TUBB2A—bone cancer	8.31e-05	0.000916	CbGpPWpGaD
Cimetidine—CYP2E1—Metapathway biotransformation—GSTP1—bone cancer	8.25e-05	0.000908	CbGpPWpGaD
Cimetidine—CYP3A5—Metapathway biotransformation—GSTP1—bone cancer	8.23e-05	0.000906	CbGpPWpGaD
Cimetidine—CYP2C9—Arachidonic acid metabolism—PTGS2—bone cancer	8.19e-05	0.000902	CbGpPWpGaD
Cimetidine—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—bone cancer	8.17e-05	0.000899	CbGpPWpGaD
Cimetidine—CYP3A7—Metabolism—NDUFA12—bone cancer	8.09e-05	0.000891	CbGpPWpGaD
Cimetidine—SLC22A2—Metabolism—NDUFA12—bone cancer	8.08e-05	0.00089	CbGpPWpGaD
Cimetidine—FMO1—Metabolism—CYP3A4—bone cancer	7.98e-05	0.000879	CbGpPWpGaD
Cimetidine—CYP1A2—Tryptophan metabolism—MDM2—bone cancer	7.76e-05	0.000855	CbGpPWpGaD
Cimetidine—CYP2C19—Biological oxidations—CYP3A4—bone cancer	7.54e-05	0.000831	CbGpPWpGaD
Cimetidine—SLC22A1—Metabolism—NDUFA12—bone cancer	7.53e-05	0.000829	CbGpPWpGaD
Cimetidine—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—bone cancer	7.48e-05	0.000824	CbGpPWpGaD
Cimetidine—CYP2C19—Metapathway biotransformation—CYP3A4—bone cancer	7.44e-05	0.000819	CbGpPWpGaD
Cimetidine—ABCB1—Integrated Pancreatic Cancer Pathway—EZH2—bone cancer	7.44e-05	0.000819	CbGpPWpGaD
Cimetidine—FMO3—Metabolism—ENO2—bone cancer	7.26e-05	0.000799	CbGpPWpGaD
Cimetidine—CYP2C8—Biological oxidations—GSTP1—bone cancer	7.23e-05	0.000796	CbGpPWpGaD
Cimetidine—CYP2C8—Metapathway biotransformation—GSTP1—bone cancer	7.13e-05	0.000785	CbGpPWpGaD
Cimetidine—HRH2—GPCR downstream signaling—GNA11—bone cancer	7.02e-05	0.000773	CbGpPWpGaD
Cimetidine—CYP1A2—Arachidonic acid metabolism—PTGS2—bone cancer	7e-05	0.000771	CbGpPWpGaD
Cimetidine—HRH2—Signaling by GPCR—SMO—bone cancer	6.97e-05	0.000767	CbGpPWpGaD
Cimetidine—CYP2D6—Biological oxidations—CYP3A4—bone cancer	6.94e-05	0.000764	CbGpPWpGaD
Cimetidine—CYP2C9—Biological oxidations—CYP3A4—bone cancer	6.88e-05	0.000758	CbGpPWpGaD
Cimetidine—CYP2D6—Metapathway biotransformation—CYP3A4—bone cancer	6.84e-05	0.000754	CbGpPWpGaD
Cimetidine—FMO1—Metabolism—GSTP1—bone cancer	6.82e-05	0.000751	CbGpPWpGaD
Cimetidine—CYP2C9—Metapathway biotransformation—CYP3A4—bone cancer	6.78e-05	0.000747	CbGpPWpGaD
Cimetidine—ABCB1—Integrated Pancreatic Cancer Pathway—IL3—bone cancer	6.77e-05	0.000746	CbGpPWpGaD
Cimetidine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—bone cancer	6.74e-05	0.000743	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—GRM4—bone cancer	6.74e-05	0.000742	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—RGS1—bone cancer	6.74e-05	0.000742	CbGpPWpGaD
Cimetidine—FMO3—Metabolism—DHFR—bone cancer	6.73e-05	0.000741	CbGpPWpGaD
Cimetidine—CYP3A7—Metabolism—NT5C3A—bone cancer	6.7e-05	0.000738	CbGpPWpGaD
Cimetidine—SLC22A2—Metabolism—NT5C3A—bone cancer	6.69e-05	0.000737	CbGpPWpGaD
Cimetidine—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—bone cancer	6.68e-05	0.000736	CbGpPWpGaD
Cimetidine—SLC22A2—Transmission across Chemical Synapses—BRAF—bone cancer	6.55e-05	0.000722	CbGpPWpGaD
Cimetidine—CYP2C19—Biological oxidations—GSTP1—bone cancer	6.45e-05	0.000711	CbGpPWpGaD
Cimetidine—HRH2—Signaling by GPCR—GNA11—bone cancer	6.37e-05	0.000702	CbGpPWpGaD
Cimetidine—CYP2C19—Metapathway biotransformation—GSTP1—bone cancer	6.36e-05	0.000701	CbGpPWpGaD
Cimetidine—HRH2—GPCR downstream signaling—IL3—bone cancer	6.36e-05	0.000701	CbGpPWpGaD
Cimetidine—ABCB1—HIF-1-alpha transcription factor network—JUN—bone cancer	6.33e-05	0.000697	CbGpPWpGaD
Cimetidine—FMO3—Metabolism—GNA11—bone cancer	6.29e-05	0.000693	CbGpPWpGaD
Cimetidine—SLC22A1—Metabolism—NT5C3A—bone cancer	6.24e-05	0.000687	CbGpPWpGaD
Cimetidine—SLC22A1—Transmission across Chemical Synapses—BRAF—bone cancer	6.11e-05	0.000673	CbGpPWpGaD
Cimetidine—CYP3A4—Tryptophan metabolism—MDM2—bone cancer	5.99e-05	0.00066	CbGpPWpGaD
Cimetidine—CYP11B1—Metabolism—ENO2—bone cancer	5.97e-05	0.000657	CbGpPWpGaD
Cimetidine—CYP2D6—Biological oxidations—GSTP1—bone cancer	5.93e-05	0.000654	CbGpPWpGaD
Cimetidine—CYP2C9—Biological oxidations—GSTP1—bone cancer	5.88e-05	0.000648	CbGpPWpGaD
Cimetidine—CYP1A2—Biological oxidations—CYP3A4—bone cancer	5.88e-05	0.000647	CbGpPWpGaD
Cimetidine—CYP2E1—Metabolism—NDUFA12—bone cancer	5.86e-05	0.000645	CbGpPWpGaD
Cimetidine—CYP2D6—Metapathway biotransformation—GSTP1—bone cancer	5.85e-05	0.000645	CbGpPWpGaD
Cimetidine—CYP3A5—Metabolism—NDUFA12—bone cancer	5.85e-05	0.000644	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—GRM1—bone cancer	5.84e-05	0.000643	CbGpPWpGaD
Cimetidine—CYP2C9—Metapathway biotransformation—GSTP1—bone cancer	5.8e-05	0.000639	CbGpPWpGaD
Cimetidine—CYP1A2—Metapathway biotransformation—CYP3A4—bone cancer	5.8e-05	0.000638	CbGpPWpGaD
Cimetidine—HRH2—Signaling by GPCR—IL3—bone cancer	5.78e-05	0.000636	CbGpPWpGaD
Cimetidine—FMO3—Metabolism—CYP3A4—bone cancer	5.7e-05	0.000628	CbGpPWpGaD
Cimetidine—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—bone cancer	5.66e-05	0.000623	CbGpPWpGaD
Cimetidine—ABCB1—Transmembrane transport of small molecules—TUBB4B—bone cancer	5.65e-05	0.000622	CbGpPWpGaD
Cimetidine—CYP11B1—Metabolism—DHFR—bone cancer	5.54e-05	0.00061	CbGpPWpGaD
Cimetidine—SLC22A2—Transmission across Chemical Synapses—MDM2—bone cancer	5.49e-05	0.000605	CbGpPWpGaD
Cimetidine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—bone cancer	5.3e-05	0.000584	CbGpPWpGaD
Cimetidine—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—bone cancer	5.3e-05	0.000584	CbGpPWpGaD
Cimetidine—CYP11B1—Metabolism—GNA11—bone cancer	5.17e-05	0.00057	CbGpPWpGaD
Cimetidine—SLC22A1—Transmission across Chemical Synapses—MDM2—bone cancer	5.12e-05	0.000564	CbGpPWpGaD
Cimetidine—CYP2C8—Metabolism—NDUFA12—bone cancer	5.07e-05	0.000558	CbGpPWpGaD
Cimetidine—CYP1A2—Biological oxidations—GSTP1—bone cancer	5.03e-05	0.000554	CbGpPWpGaD
Cimetidine—SLC22A2—Neuronal System—BRAF—bone cancer	5.02e-05	0.000553	CbGpPWpGaD
Cimetidine—CYP1A2—Metapathway biotransformation—GSTP1—bone cancer	4.96e-05	0.000546	CbGpPWpGaD
Cimetidine—FMO3—Metabolism—GSTP1—bone cancer	4.88e-05	0.000537	CbGpPWpGaD
Cimetidine—ABCB1—Transmembrane transport of small molecules—TUBB2A—bone cancer	4.87e-05	0.000537	CbGpPWpGaD
Cimetidine—CYP2E1—Metabolism—NT5C3A—bone cancer	4.86e-05	0.000535	CbGpPWpGaD
Cimetidine—CYP3A5—Metabolism—NT5C3A—bone cancer	4.85e-05	0.000534	CbGpPWpGaD
Cimetidine—CYP11B1—Metabolism—CYP3A4—bone cancer	4.69e-05	0.000517	CbGpPWpGaD
Cimetidine—SLC22A1—Neuronal System—BRAF—bone cancer	4.68e-05	0.000515	CbGpPWpGaD
Cimetidine—SLC22A3—Metabolism—ENO2—bone cancer	4.68e-05	0.000515	CbGpPWpGaD
Cimetidine—CYP11B1—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	4.67e-05	0.000514	CbGpPWpGaD
Cimetidine—CYP2C19—Metabolism—NDUFA12—bone cancer	4.52e-05	0.000498	CbGpPWpGaD
Cimetidine—ABCB11—Metabolism—ENO2—bone cancer	4.48e-05	0.000494	CbGpPWpGaD
Cimetidine—ABCB1—Metabolism—NDUFA12—bone cancer	4.41e-05	0.000486	CbGpPWpGaD
Cimetidine—SLC22A3—Metabolism—DHFR—bone cancer	4.34e-05	0.000478	CbGpPWpGaD
Cimetidine—SLC22A2—Neuronal System—MDM2—bone cancer	4.21e-05	0.000463	CbGpPWpGaD
Cimetidine—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	4.2e-05	0.000462	CbGpPWpGaD
Cimetidine—CYP2C8—Metabolism—NT5C3A—bone cancer	4.2e-05	0.000462	CbGpPWpGaD
Cimetidine—CYP2D6—Metabolism—NDUFA12—bone cancer	4.16e-05	0.000458	CbGpPWpGaD
Cimetidine—ABCB11—Metabolism—DHFR—bone cancer	4.16e-05	0.000458	CbGpPWpGaD
Cimetidine—CYP2C9—Metabolism—NDUFA12—bone cancer	4.12e-05	0.000454	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—SMO—bone cancer	4.12e-05	0.000453	CbGpPWpGaD
Cimetidine—SLC22A3—Metabolism—GNA11—bone cancer	4.05e-05	0.000446	CbGpPWpGaD
Cimetidine—CYP11B1—Metabolism—GSTP1—bone cancer	4.01e-05	0.000442	CbGpPWpGaD
Cimetidine—SLC22A1—Neuronal System—MDM2—bone cancer	3.92e-05	0.000432	CbGpPWpGaD
Cimetidine—ABCB11—Metabolism—GNA11—bone cancer	3.89e-05	0.000428	CbGpPWpGaD
Cimetidine—CYP3A4—Biological oxidations—GSTP1—bone cancer	3.88e-05	0.000427	CbGpPWpGaD
Cimetidine—CYP3A4—Metapathway biotransformation—GSTP1—bone cancer	3.83e-05	0.000421	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—GNA11—bone cancer	3.76e-05	0.000415	CbGpPWpGaD
Cimetidine—CYP2C19—Metabolism—NT5C3A—bone cancer	3.75e-05	0.000413	CbGpPWpGaD
Cimetidine—SLC22A3—Metabolism—CYP3A4—bone cancer	3.68e-05	0.000405	CbGpPWpGaD
Cimetidine—ABCB1—Metabolism—NT5C3A—bone cancer	3.66e-05	0.000403	CbGpPWpGaD
Cimetidine—FMO1—Metabolism—PTGS2—bone cancer	3.53e-05	0.000389	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism—NDUFA12—bone cancer	3.52e-05	0.000388	CbGpPWpGaD
Cimetidine—ABCB11—Metabolism—CYP3A4—bone cancer	3.52e-05	0.000388	CbGpPWpGaD
Cimetidine—ABCB11—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	3.51e-05	0.000386	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—ATF1—bone cancer	3.5e-05	0.000385	CbGpPWpGaD
Cimetidine—CYP2D6—Metabolism—NT5C3A—bone cancer	3.45e-05	0.00038	CbGpPWpGaD
Cimetidine—CYP2C9—Metabolism—NT5C3A—bone cancer	3.42e-05	0.000376	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—IL3—bone cancer	3.41e-05	0.000376	CbGpPWpGaD
Cimetidine—SLC22A3—Metabolism—GSTP1—bone cancer	3.14e-05	0.000346	CbGpPWpGaD
Cimetidine—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	3.11e-05	0.000343	CbGpPWpGaD
Cimetidine—ABCB11—Metabolism—GSTP1—bone cancer	3.01e-05	0.000332	CbGpPWpGaD
Cimetidine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—bone cancer	3e-05	0.00033	CbGpPWpGaD
Cimetidine—CYP3A7—Metabolism—ENO2—bone cancer	2.94e-05	0.000323	CbGpPWpGaD
Cimetidine—SLC22A2—Metabolism—ENO2—bone cancer	2.93e-05	0.000323	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism—NT5C3A—bone cancer	2.92e-05	0.000322	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—TGFBR2—bone cancer	2.92e-05	0.000321	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—IGF1R—bone cancer	2.75e-05	0.000302	CbGpPWpGaD
Cimetidine—SLC22A1—Metabolism—ENO2—bone cancer	2.73e-05	0.000301	CbGpPWpGaD
Cimetidine—CYP3A7—Metabolism—DHFR—bone cancer	2.72e-05	0.0003	CbGpPWpGaD
Cimetidine—SLC22A2—Metabolism—DHFR—bone cancer	2.72e-05	0.0003	CbGpPWpGaD
Cimetidine—CYP3A4—Metabolism—NDUFA12—bone cancer	2.72e-05	0.000299	CbGpPWpGaD
Cimetidine—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	2.71e-05	0.000298	CbGpPWpGaD
Cimetidine—CYP3A7—Metabolism—GNA11—bone cancer	2.55e-05	0.00028	CbGpPWpGaD
Cimetidine—SLC22A2—Metabolism—GNA11—bone cancer	2.54e-05	0.00028	CbGpPWpGaD
Cimetidine—SLC22A1—Metabolism—DHFR—bone cancer	2.54e-05	0.000279	CbGpPWpGaD
Cimetidine—FMO3—Metabolism—PTGS2—bone cancer	2.53e-05	0.000278	CbGpPWpGaD
Cimetidine—SLC22A1—Metabolism—GNA11—bone cancer	2.37e-05	0.000261	CbGpPWpGaD
Cimetidine—CYP3A7—Metabolism—CYP3A4—bone cancer	2.31e-05	0.000254	CbGpPWpGaD
Cimetidine—SLC22A2—Metabolism—CYP3A4—bone cancer	2.3e-05	0.000254	CbGpPWpGaD
Cimetidine—CYP3A4—Metabolism—NT5C3A—bone cancer	2.25e-05	0.000248	CbGpPWpGaD
Cimetidine—SLC22A1—Metabolism—CYP3A4—bone cancer	2.15e-05	0.000237	CbGpPWpGaD
Cimetidine—CYP2E1—Metabolism—ENO2—bone cancer	2.13e-05	0.000234	CbGpPWpGaD
Cimetidine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	2.13e-05	0.000234	CbGpPWpGaD
Cimetidine—CYP3A5—Metabolism—ENO2—bone cancer	2.12e-05	0.000234	CbGpPWpGaD
Cimetidine—CYP11B1—Metabolism—PTGS2—bone cancer	2.08e-05	0.000229	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—KIT—bone cancer	1.99e-05	0.000219	CbGpPWpGaD
Cimetidine—CYP3A7—Metabolism—GSTP1—bone cancer	1.97e-05	0.000217	CbGpPWpGaD
Cimetidine—CYP2E1—Metabolism—DHFR—bone cancer	1.97e-05	0.000217	CbGpPWpGaD
Cimetidine—SLC22A2—Metabolism—GSTP1—bone cancer	1.97e-05	0.000217	CbGpPWpGaD
Cimetidine—CYP3A5—Metabolism—DHFR—bone cancer	1.97e-05	0.000217	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—BRAF—bone cancer	1.87e-05	0.000206	CbGpPWpGaD
Cimetidine—CYP2E1—Metabolism—GNA11—bone cancer	1.84e-05	0.000203	CbGpPWpGaD
Cimetidine—CYP3A5—Metabolism—GNA11—bone cancer	1.84e-05	0.000203	CbGpPWpGaD
Cimetidine—CYP2C8—Metabolism—ENO2—bone cancer	1.84e-05	0.000203	CbGpPWpGaD
Cimetidine—SLC22A1—Metabolism—GSTP1—bone cancer	1.84e-05	0.000202	CbGpPWpGaD
Cimetidine—HRH2—Signaling by GPCR—EGFR—bone cancer	1.81e-05	0.0002	CbGpPWpGaD
Cimetidine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	1.79e-05	0.000197	CbGpPWpGaD
Cimetidine—CYP2C8—Metabolism—DHFR—bone cancer	1.71e-05	0.000188	CbGpPWpGaD
Cimetidine—CYP2E1—Metabolism—CYP3A4—bone cancer	1.67e-05	0.000184	CbGpPWpGaD
Cimetidine—CYP3A5—Metabolism—CYP3A4—bone cancer	1.67e-05	0.000184	CbGpPWpGaD
Cimetidine—CYP2C19—Metabolism—ENO2—bone cancer	1.64e-05	0.000181	CbGpPWpGaD
Cimetidine—SLC22A3—Metabolism—PTGS2—bone cancer	1.63e-05	0.000179	CbGpPWpGaD
Cimetidine—ABCB1—Metabolism—ENO2—bone cancer	1.6e-05	0.000176	CbGpPWpGaD
Cimetidine—CYP2C8—Metabolism—GNA11—bone cancer	1.59e-05	0.000176	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—MDM2—bone cancer	1.57e-05	0.000173	CbGpPWpGaD
Cimetidine—ABCB11—Metabolism—PTGS2—bone cancer	1.56e-05	0.000172	CbGpPWpGaD
Cimetidine—CYP2C19—Metabolism—DHFR—bone cancer	1.52e-05	0.000168	CbGpPWpGaD
Cimetidine—CYP2D6—Metabolism—ENO2—bone cancer	1.51e-05	0.000166	CbGpPWpGaD
Cimetidine—CYP2C9—Metabolism—ENO2—bone cancer	1.5e-05	0.000165	CbGpPWpGaD
Cimetidine—ABCB1—Metabolism—DHFR—bone cancer	1.49e-05	0.000164	CbGpPWpGaD
Cimetidine—CYP2C8—Metabolism—CYP3A4—bone cancer	1.45e-05	0.000159	CbGpPWpGaD
Cimetidine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.44e-05	0.000158	CbGpPWpGaD
Cimetidine—CYP2E1—Metabolism—GSTP1—bone cancer	1.43e-05	0.000158	CbGpPWpGaD
Cimetidine—CYP3A5—Metabolism—GSTP1—bone cancer	1.43e-05	0.000157	CbGpPWpGaD
Cimetidine—CYP2C19—Metabolism—GNA11—bone cancer	1.42e-05	0.000157	CbGpPWpGaD
Cimetidine—CYP2D6—Metabolism—DHFR—bone cancer	1.4e-05	0.000154	CbGpPWpGaD
Cimetidine—ABCB1—Metabolism—GNA11—bone cancer	1.39e-05	0.000153	CbGpPWpGaD
Cimetidine—CYP2C9—Metabolism—DHFR—bone cancer	1.39e-05	0.000153	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—JUN—bone cancer	1.36e-05	0.00015	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—MMP9—bone cancer	1.33e-05	0.000146	CbGpPWpGaD
Cimetidine—CYP2D6—Metabolism—GNA11—bone cancer	1.31e-05	0.000144	CbGpPWpGaD
Cimetidine—CYP2C9—Metabolism—GNA11—bone cancer	1.3e-05	0.000143	CbGpPWpGaD
Cimetidine—CYP2C19—Metabolism—CYP3A4—bone cancer	1.29e-05	0.000142	CbGpPWpGaD
Cimetidine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.28e-05	0.000141	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism—ENO2—bone cancer	1.28e-05	0.000141	CbGpPWpGaD
Cimetidine—ABCB1—Metabolism—CYP3A4—bone cancer	1.26e-05	0.000139	CbGpPWpGaD
Cimetidine—CYP2C8—Metabolism—GSTP1—bone cancer	1.24e-05	0.000136	CbGpPWpGaD
Cimetidine—CYP2D6—Metabolism—CYP3A4—bone cancer	1.19e-05	0.000131	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism—DHFR—bone cancer	1.19e-05	0.000131	CbGpPWpGaD
Cimetidine—CYP2C9—Metabolism—CYP3A4—bone cancer	1.18e-05	0.00013	CbGpPWpGaD
Cimetidine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.17e-05	0.000129	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism—GNA11—bone cancer	1.11e-05	0.000122	CbGpPWpGaD
Cimetidine—CYP2C19—Metabolism—GSTP1—bone cancer	1.1e-05	0.000122	CbGpPWpGaD
Cimetidine—ABCB1—Metabolism—GSTP1—bone cancer	1.08e-05	0.000119	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—EGFR—bone cancer	1.07e-05	0.000118	CbGpPWpGaD
Cimetidine—CYP3A7—Metabolism—PTGS2—bone cancer	1.02e-05	0.000113	CbGpPWpGaD
Cimetidine—SLC22A2—Metabolism—PTGS2—bone cancer	1.02e-05	0.000112	CbGpPWpGaD
Cimetidine—CYP2D6—Metabolism—GSTP1—bone cancer	1.01e-05	0.000112	CbGpPWpGaD
Cimetidine—CYP2C9—Metabolism—GSTP1—bone cancer	1.01e-05	0.000111	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism—CYP3A4—bone cancer	1.01e-05	0.000111	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1e-05	0.00011	CbGpPWpGaD
Cimetidine—CYP3A4—Metabolism—ENO2—bone cancer	9.87e-06	0.000109	CbGpPWpGaD
Cimetidine—SLC22A1—Metabolism—PTGS2—bone cancer	9.52e-06	0.000105	CbGpPWpGaD
Cimetidine—CYP3A4—Metabolism—DHFR—bone cancer	9.16e-06	0.000101	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—TP53—bone cancer	9e-06	9.91e-05	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism—GSTP1—bone cancer	8.6e-06	9.47e-05	CbGpPWpGaD
Cimetidine—CYP3A4—Metabolism—GNA11—bone cancer	8.56e-06	9.42e-05	CbGpPWpGaD
Cimetidine—CYP2E1—Metabolism—PTGS2—bone cancer	7.41e-06	8.16e-05	CbGpPWpGaD
Cimetidine—CYP3A5—Metabolism—PTGS2—bone cancer	7.39e-06	8.14e-05	CbGpPWpGaD
Cimetidine—CYP3A4—Metabolism—GSTP1—bone cancer	6.64e-06	7.31e-05	CbGpPWpGaD
Cimetidine—CYP2C8—Metabolism—PTGS2—bone cancer	6.4e-06	7.05e-05	CbGpPWpGaD
Cimetidine—CYP2C19—Metabolism—PTGS2—bone cancer	5.72e-06	6.3e-05	CbGpPWpGaD
Cimetidine—ABCB1—Metabolism—PTGS2—bone cancer	5.58e-06	6.14e-05	CbGpPWpGaD
Cimetidine—CYP2D6—Metabolism—PTGS2—bone cancer	5.26e-06	5.79e-05	CbGpPWpGaD
Cimetidine—CYP2C9—Metabolism—PTGS2—bone cancer	5.21e-06	5.74e-05	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism—PTGS2—bone cancer	4.45e-06	4.91e-05	CbGpPWpGaD
Cimetidine—CYP3A4—Metabolism—PTGS2—bone cancer	3.44e-06	3.79e-05	CbGpPWpGaD
